Exenatide (exendin-4) studies: 530 papers with results
Page 4 of 11
- Effects of exenatide on microvascular reactivity in patients with type 2 diabetes and coronary artery disease: A randomized controlled study.
Östlund Papadogeorgos N · Microcirculation (New York, N.Y. : 1994) · 2021
Randomized controlled trial · 4 results
- Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady-state concentrations.
Jones KL · Diabetes, obesity & metabolism · 2020
Randomized controlled trial · 8 results
- Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial.
Kothare PA · BMC clinical pharmacology · 2012
Randomized controlled trial · 12 results
- Exenatide reduces urinary transforming growth factor-β1 and type IV collagen excretion in patients with type 2 diabetes and microalbuminuria.
Zhang H · Kidney & blood pressure research · 2012
Randomized controlled trial · 4 results
- One-year treatment with exenatide vs. insulin glargine: effects on postprandial glycemia, lipid profiles, and oxidative stress.
Bunck MC · Atherosclerosis · 2010
Randomized controlled trial · 7 results
- Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL · Clinical therapeutics · 2008
Randomized controlled trial · 8 results
- The effects of add-on exenatide to insulin on glycemic variability and hypoglycemia in patients with type 1 diabetes mellitus.
Jiang LL · Journal of endocrinological investigation · 2018
Randomized controlled trial · 16 results
- The effects of exenatide and insulin glargine treatments on bone turnover markers and bone mineral density in postmenopausal patients with type 2 diabetes mellitus.
Akyay OZ · Medicine · 2023
Randomized controlled trial · 8 results
- Improvement of postprandial endothelial function after a single dose of exenatide in individuals with impaired glucose tolerance and recent-onset type 2 diabetes.
Koska J · Diabetes care · 2010
Randomized controlled trial · 2 results
- Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study.
Hepprich M · European journal of endocrinology · 2025
Randomized controlled trial · 7 results
- [Effects of GLP-1 Agonist Exenatide on Cardiac Diastolic Function and Vascular Endothelial Function in Diabetic Patients].
Wang XH · Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2015
Randomized controlled trial · 11 results
- Comparison of the effects of exenatide and insulin glargine on right and left ventricular myocardial deformation as shown by 2D-speckle-tracking echocardiograms.
Akyay OZ · Nigerian journal of clinical practice · 2022
Randomized controlled trial · 8 results
- The use of exenatide in severely burned pediatric patients.
Mecott GA · Critical care (London, England) · 2010
Randomized controlled trial · 4 results
- Exenatide Increases IL-1RA Concentration and Induces Nrf-2‒Keap-1‒Regulated Antioxidant Enzymes: Relevance to β-Cell Function.
Dandona P · The Journal of clinical endocrinology and metabolism · 2018
Randomized controlled trial · 7 results
- Exenatide pharmacokinetics in healthy Chinese subjects.
Zhao X · International journal of clinical pharmacology and therapeutics · 2008
Randomized controlled trial · 13 results
- Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus.
Wu JD · Diabetes technology & therapeutics · 2011
Randomized controlled trial · 11 results
- Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes.
Scalzo RL · Journal of diabetes and its complications · 2017
Randomized controlled trial · 5 results
- Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial.
Samson SL · Diabetologia · 2011
Randomized controlled trial · 11 results
- The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
Thazhath SS · Diabetes · 2016
Randomized controlled trial · 7 results
- Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study.
Acosta A · Physiological reports · 2015
Randomized controlled trial · 7 results
- Preventive effects of exenatide on endothelial dysfunction induced by ischemia-reperfusion injury via KATP channels.
Ha SJ · Arteriosclerosis, thrombosis, and vascular biology · 2012
Randomized controlled trial · 5 results
- Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes.
Li R · Acta diabetologica · 2015
Randomized controlled trial · 6 results
- Study of postprandial lipaemia in type 2 diabetes mellitus: exenatide versus liraglutide.
Voukali M · Journal of diabetes research · 2014
Randomized controlled trial · 5 results
- Effect of administration time of exenatide on satiety responses, blood glucose, and adverse events in healthy volunteers.
Pinelli NR · Journal of clinical pharmacology · 2011
Randomized controlled trial · 11 results
- Exenatide: effect of injection time on postprandial glucose in patients with Type 2 diabetes.
Linnebjerg H · Diabetic medicine : a journal of the British Diabetic Association · 2006
Randomized controlled trial · 8 results
- Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes.
Linnebjerg H · Regulatory peptides · 2008
Randomized controlled trial · 8 results
- Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans.
Xiao C · Arteriosclerosis, thrombosis, and vascular biology · 2012
Randomized controlled trial · 4 results
- Exenatide Regulates Cerebral Glucose Metabolism in Brain Areas Associated With Glucose Homeostasis and Reward System.
Daniele G · Diabetes · 2015
Randomized controlled trial · 6 results
- Acute Exenatide Therapy Attenuates Postprandial Vasodilation in Humans with Prediabetes: A Randomized Controlled Trial.
Hamidi V · Metabolic syndrome and related disorders · 2020
Randomized controlled trial · 11 results
- Exenatide exerts a potent antiinflammatory effect.
Chaudhuri A · The Journal of clinical endocrinology and metabolism · 2012
Randomized controlled trial · 24 results
- Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia.
Degn KB · Diabetes · 2004
Randomized controlled trial · 11 results
- Effects of exenatide on cardiac function, perfusion, and energetics in type 2 diabetic patients with cardiomyopathy: a randomized controlled trial against insulin glargine.
Chen WJY · Cardiovascular diabetology · 2017
Randomized controlled trial · 4 results
- Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
Thazhath SS · Diabetes & vascular disease research · 2017
Randomized controlled trial · 5 results
- Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes.
Gejl M · The Journal of clinical endocrinology and metabolism · 2012
Randomized controlled trial · 6 results
- The role of adjunctive exenatide therapy in pediatric type 1 diabetes.
Raman VS · Diabetes care · 2010
Randomized controlled trial · 3 results
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of exenatide once weekly in Japanese patients with type 2 diabetes.
Iwamoto K · Endocrine journal · 2009
Randomized controlled trial · 13 results
- Acute effects of glucagon-like peptide-1, GLP-19-36 amide, and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers.
Bremholm L · Physiological reports · 2017
Randomized controlled trial · 5 results
- A randomized, open-label, crossover study examining the effect of injection site on bioavailability of exenatide (synthetic exendin-4).
Calara F · Clinical therapeutics · 2005
Randomized controlled trial · 17 results
- Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.
DeFronzo RA · Diabetes care · 2005
Randomized controlled trial · 9 results
- Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea.
Kendall DM · Diabetes care · 2005
Randomized controlled trial · 9 results
- Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus.
Kolterman OG · American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2005
Randomized controlled trial · 8 results
- A Pilot Study of Exenatide Actions in Alzheimer's Disease.
Mullins RJ · Current Alzheimer research · 2019
Randomized controlled trial · 7 results
- Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study.
Arnolds S · Diabetes care · 2010
Randomized controlled trial · 12 results
- Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body composition.
Bunck MC · Diabetes care · 2010
Randomized controlled trial · 6 results
- Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin.
DeFronzo RA · Diabetes care · 2010
Randomized controlled trial · 11 results
- Safety and Efficacy of Exenatide Once Weekly Plus Dapagliflozin Once Daily Versus Exenatide or Dapagliflozin Alone in Patients With Type 2 Diabetes Inadequately Controlled With Metformin Monotherapy: 52-Week Results of the DURATION-8 Randomized Controlled Trial.
Jabbour SA · Diabetes care · 2018
Randomized controlled trial · 12 results
- Exenatide, Dapagliflozin, or Phentermine/Topiramate Differentially Affect Metabolic Profiles in Polycystic Ovary Syndrome.
Elkind-Hirsch KE · The Journal of clinical endocrinology and metabolism · 2021
Randomized controlled trial · 4 results
- Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.
Bergenstal R · Current medical research and opinion · 2009
Randomized controlled trial · 9 results
- Exenatide-induced reduction in energy intake is associated with increase in hypothalamic connectivity.
Schlögl H · Diabetes care · 2013
Randomized controlled trial · 2 results
- Impact of acute hyperglycemia on myocardial infarct size, area at risk, and salvage in patients with STEMI and the association with exenatide treatment: results from a randomized study.
Lønborg J · Diabetes · 2014
Randomized controlled trial · 2 results